Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Bullboard Posts
Post by PutinKhuylo1on Aug 03, 2017 1:46pm
497 Views
Post# 26543932

My Take

My TakeI was a stockholder much longer than a SH poster. I traded SBM in the beginning (note: NOT flipped), then began accumulating when it dropped precipitously to below a nickel. I've participated in 4 private placements and exercised options. I have not sold a single share since. The transition came as a result of getting to understand the science behind the company. Through the years I've spoken to most of the major players in the company, i.e. Howard Verrico and Neil Belenke, met some of them in person, and even lunched with Attila Hajdu in Philly at a BIO-conference. Quite frankly, I liked all of them. Because of the financial aspects of my connection with SBM, the most exposure has been to Chris Hopton, the CFO, who I believe is as honest as the day is long. Perhaps these relationships are the reason I get upset when I hear mindless buffoons recklessly throwing around unsubstantiated accusations and innuendo. There are real, competent people here who have invested plenty and continue to push this company forward. The mere reality that we're still around as a penny stock on the Venture and in transformational negotiations of any kind (yes, I believe) is a testament to that dedication. Nothing is handed to you on a silver platter. Nothing. Remember also, it takes a few weeks to grow a pumpkin, but decades to cultivate a mighty oak. Hang in there! 
Bullboard Posts